ALZAMER® DepotTM Bioerodible Polymer Technology

2002 
With the advent of therapeutic biomolecules produced by the biotechnology industry, the need for convenient sustained delivery of proteins and other biomolecules has greatly increased. The Alzamer Depot technology was designed to offer sustained delivery of therapeutic agents, including proteins, peptides, other biomolecules, and small-molecular-weight compounds, for up to a month with minimal initial drug burst, and bioerosion of the dosage form.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    48
    References
    19
    Citations
    NaN
    KQI
    []